New and Emerging Therapies

Volume 02, Issue 16
June 2011

MP3

New and Emerging Therapies

Interview with:

Peter Campochiaro, MD, George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience, Johns Hopkins University, Wilmer Eye Institute, Baltimore, MD

Injectable therapies: Advantages and disadvantages

Injection risks: All ocular injections are associated with risk for infection at the injection site, which is the primary known risk associated with the anti-VEGF therapies (»1 in 5,000...